LRRK2 Monoclonal Antibody
Applications
Predicted Reactivity
| Overview | |
| Catalog # | bsm-51545m |
| Product Name | LRRK2 Monoclonal Antibody |
| Applications |
WB
IHC-F
IF
IHC-P
|
| Predicted Reactivity | Human, Mouse |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Mouse |
| Source | Recombinant human PARK8 (LRRK2) (Fragment) (His-tagged). |
| Clonality | Monoclonal |
| Clone # | L2F6 |
| Isotype | IgG1 |
| Concentration | Lot Dependent |
| Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 120892 |
| Swiss Prot | Q5S007 |
| Subcellular location | Cytoplasm, Cell membrane |
| Synonyms | Dardarin; Leucine rich repeat kinase 2; LRRK 2; LRRK-2; PARK 8; PARK8; ROCO 2; ROCO-2; ROCO2; Leucine-rich repeat serine/threonine-protein kinase 2; Dardarin; LRRK2_HUMAN; augmented in rheumatoid arthritis 17; AURA17; Leucine rich repeat kinase 2; RIPK7. |
| Background | May play a role in the phosphorylation of proteins central to Parkinson disease. Phosphorylates PRDX3. May also have GTPase activity. |
| Application Dilution | |
| WB | =1:500-1000 |
| IHC-F | IHC-F=1:400-800 |
| IF | IF=1:50-200 |
| IHC-P | IHC-P=1:100-500 |
Frequently asked questions
Which applications is LRRK2 Monoclonal Antibody (bsm-51545M) validated for, and at what dilution?
bsm-51545M is validated for WB (WB=1:500-1000); IHC-F (IHC-F=1:400-800); IF (IF=1:50-200); IHC-P (IHC-P=1:100-500). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
How should bsm-51545M be stored?
Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. Storage buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise LRRK2 Monoclonal Antibody (bsm-51545M)?
Recombinant human PARK8 (LRRK2) (Fragment) (His-tagged).